Endpoints News
Max Bayer is a skilled journalist with extensive experience in pharmaceutical and breaking news reporting. Currently serving as a Pharma Reporter for Endpoints News since May 2024, Max previously held positions at FierceMarkets as Senior Writer and Staff Writer, focusing on drug development and investor financing in the biotech sector. Prior roles include reporting and researching COVID-19 trends for CBS News, where responsibilities encompassed data collection and analysis for broadcast, as well as fact-checking for the CBS Evening News. Earlier experience includes serving as an Associate Producer for the Milwaukee Journal Sentinel and holding various roles at The Daily Cardinal, where Max significantly contributed to city news coverage and investigative reporting. Max holds a Bachelor's Degree in Journalism and a Digital Studies certificate from the University of Wisconsin-Madison.
This person is not in any teams
This person is not in any offices
Endpoints News
Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day. They produce original editorial on a daily basis on business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world’s most closely watched drugs. In this organization, the editors have complete authority to call the news as they see it.